Olave's Blood Clot Recovery Extends Past Six Months; Saints Proceed With Caution Into 2026

Chris Olave has not participated in team drills during New Orleans' offseason practices, more than six months after a pulmonary blood clot ended his 2025 season. The Saints are managing his return with deliberate restraint—he has been present at OTAs but remains uninvolved in competitive team work. This marks a significant departure from the four-week recovery window originally projected, signaling either medical complications or organizational caution around a talent the franchise intends to pay franchise-level money.

Olave's contract situation amplifies the stakes. He is due $3.33 million this season with a $15.49 million fifth-year option in 2027, but the real negotiation is over long-term security—potentially $100 million or more in guarantees. The Saints are not protecting a backup. They are protecting an investment they plan to anchor their passing game around for five-plus years. A blood clot in the lung is a medical event that does not resolve on a linear timeline; it demands imaging confirmation, anticoagulation protocols, and clearance from both team physicians and independent cardiologists. New Orleans is signaling through its actions that full clearance is not yet certain.

For betting purposes, Olave's absence has immediate passing-game consequences. The Saints leaned heavily on him in 2025—he was on pace for 1,200+ receiving yards before his injury. His absence forces the offense to distribute targets to Rashid Shaheed, Tre'Quan Smith, and the tight-end group. This is not a neutral adjustment. Olave commands defensive attention and operates in intermediate/vertical routes that generated explosive plays; his deputies operate at lower leverage. If Olave remains unavailable into training camp or even the regular season, the Saints' passing-yard totals and individual receiver yardage props will compress across the board.

The timeline is the real tell. June 13, 2026, puts us six months post-injury (from late December 2025), yet Olave is still not cleared for team drills. In uncomplicated pulmonary blood-clot cases, athletes typically return to competition within 8-12 weeks with appropriate anticoagulation. That Olave has not hit this mark suggests either a recurrent clot, a particularly severe initial event, or a conservative organizational stance reflecting the franchise's financial commitment. All three scenarios imply elevated risk of continued unavailability through the preseason.

Bettors should treat Saints passing-game props—particularly Olave receiving-yards totals and team passing-yard targets—as depressed relative to 2025 baselines until Olave logs full-contact practice reps. If he returns before the season starts, expect sharp adjustment within 24-48 hours of the first news. If he enters Week 1 still ramping up or remains unavailable, lean toward passing-yard unders for New Orleans for the first 2-4 weeks of the regular season.